Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation

Vaccine

Volumn 25, Issue 36, 2007, Pages 6635-6645

  Dobaño, Carlota ^a,b,c   Widera, Georg ^d   Rabussay, Dietmar ^d   Doolan, Denise L ^a,e  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d Inovio Biomedical Corporation   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

DNA vaccine; Electroporation; Malaria

Indexed keywords

ANTIGEN PYCSP; ANTIGEN PYHEP17; BACTERIAL ANTIGEN; DNA VACCINE; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPORATION; FEMALE; GENETIC CODE; IN VIVO STUDY; MALARIA; MOUSE; NEEDLE; NONHUMAN; PLASMID; PLASMODIUM YOELII; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ELECTROPORATION; FEMALE; IMMUNITY, CELLULAR; IMMUNIZATION; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; LIVER; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMIDS; PLASMODIUM YOELII; VACCINES, DNA;

EID: 34547667395     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.06.036     Document Type: Article

References (66)

1. Smooker P.M., Rainczuk A., Kennedy N., and Spithill T.W. DNA vaccines and their application against parasites-promise, limitations and potential solutions. Biotechnol Annu Rev 10 (2004) 189-236
2. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J Immunol 175 (2005) 633-639
3. Liu M.A., and Ulmer J.B. Human clinical trials of plasmid DNA vaccines. Adv Genet 55 (2005) 25-40
4. Wolff J.A., and Budker V. The mechanism of naked DNA uptake and expression. Adv Genet 54 (2005) 3-20
5. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 (1998) 476-480
6. Sedegah M., Hedstrom R., Hobart P., and Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 91 (1994) 9866-9870
7. Doolan D.L., Hedstrom R.C., Rogers W.O., Charoenvit Y., Rogers M., De la Vega P., et al. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J Biol Chem 271 (1996) 17861-17868
8. Doolan D.L., and Martinez-Alier N. Immune response to pre-erythrocytic stages of malaria parasites. Curr Mol Med 6 (2006) 169-185
9. Charoenvit Y., Mellouk S., Sedegah M., Toyoshima T., Leef M.F., De la Vega P., et al. Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody. Exp Parasitol 80 (1995) 419-429
10. Doolan D.L., Sedegah M., Hedstrom R.C., Hobart P., Charoenvit Y., and Hoffman S.L. Circumventing genetic restriction of protection against malaria with multi-gene DNA immunization: CD8+ T cell, interferon-γ, and nitric oxide dependent immunity. J Exp Med 183 (1996) 1739-1746
11. Sedegah M., Jones T.R., Kaur M., Hedstrom R.C., Hobart P., Tine J.A., et al. Boosting with recombinant vaccine increases immunogenicity and protective efficacy of malaria DNA vaccine. Proceedings of the National Academy of Sciences of the United States of America, vol. 95 (1998) 7648-7653
12. Dobaño C., and Doolan D.L. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17 kDa. Mol Immunol 44 (2007) 3037-3048
13. Gramzinski R.A., Maris D.C., Doolan D., Charoenvit Y., Obaldia N., Rossan R., et al. Malaria DNA vaccines in Aotus monkeys. Vaccine 15 (1997) 913-915
14. Fuller D.H., Loudon P., and Schmaljohn C. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40 (2006) 86-97
15. Chen D., Maa Y.F., and Haynes J.R. Needle-free epidermal powder immunization. Expert Rev Vaccines 1 (2002) 265-276
16. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., Robinson H.L., Santoro J.C., Fuller J.T., et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5 (1999) 287-300
17. Good M.F., and Doolan D.L. Immune effector mechanisms in malaria. Curr Opin Immunol 11 (1999) 412-419
18. Doolan D.L., Hedstrom R.C., Wang R., Sedegah M., Scheller L.F., Hobart P., et al. DNA vaccines for malaria: the past, the present, & the future. Indian J Med Res 106 (1997) 109-119
19. Nishi T., Yoshizato K., Yamashiro S., Takeshima H., Sato K., Hamada K., et al. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res 56 (1996) 1050-1055
20. McMahon J.M., and Wells D.J. Electroporation for gene transfer to skeletal muscles: current status. Bio Drugs 18 (2004) 155-165
21. Andre F., and Mir L.M. DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11 (2004) S33-S42
22. Mir L.M., Moller P.H., Andre F., and Gehl J. Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54 (2005) 83-114
23. Weaver J.C., and Chizmadzhev Y.A. Bioelectrochem. Bioenerget. 41 (1996) 135-160
24. Neumann E., Sowere A.E., and Jordan C.A. Electroporation and Electrofusion in Cell Biology (1989), Plenum Press, New York
25. Hofmann G.A. In: Jaroszeski M.J., Heller R., and Gilbert R. (Eds). Methods in Molecular Medicine vol. 37 (2000), Humana Press, Inc., Totowa, NJ 37-61
26. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16 (1998) 867-870
27. Mir L.M., Bureau M.F., Rangara R., Schwartz B., and Scherman D. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 321 (1998) 893-899
28. Zucchelli S., Capone S., Fattori E., Folgori A., Di Marco A., Casimiro D., et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 74 (2000) 11598-11607
29. Selby M., Goldbeck C., Pertile T., Walsh R., and Ulmer J. Enhancement of DNA vaccine potency by electroporation in vivo. J Biotechnol 83 (2000) 147-152
30. Mir L.M., Bureau M.F., Gehl J., Rangara R., Rouy D., Caillaud J.M., et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 96 (1999) 4262-4267
31. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 (2000) 4635-4640
32. Babiuk S., Baca-Estrada M.E., Foldvari M., Middleton D.M., Rabussay D., Widera G., et al. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J Biotechnol 110 (2004) 1-10
33. Otten G., Schaefer M., Doe B., Liu H., Srivastava I., zur Megede J., et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22 (2004) 2489-2493
34. Otten G.R., Schaefer M., Doe B., Liu H., Megede J.Z., Donnelly J., et al. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine 24 (2006) 4503-4509 [epub 2005 Aug 19]
35. Zhang L., Widera G., and Rabussay D. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant. Bioelectrochemistry 63 (2004) 369-373
36. Muramatsu T., Nakamura A., and Park H.M. In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals. Int J Mol Med 1 (1998) 55-62 [review]
37. Luke C.J., Carner K., Liang X., and Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J Infect Dis 175 (1997) 91-97
38. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
39. Charoenvit Y., Leef M.L., Yuan L.F., Sedegah M., and Beaudoin R.L. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Infect Immunol 55 (1987) 604-608
40. Charoenvit Y., Mellouk S., Cole C., Bechara R., Leef M.F., Sedegah M., et al. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoelli sporozoites. J Immunol 146 (1991) 1020-1025
41. Witney A.A., Doolan D.L., Anthony R.M., Weiss W.R., Hoffman S.L., and Carucci D.J. Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy. Mol Biochem Parasitol 118 (2001) 233-245
42. Tuting T., Storkus W.J., and Falo Jr. L.D. DNA immunization targeting the skin: molecular control of adaptive immunity. J Invest Dermatol 111 (1998) 183-188
43. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Sata T., Kurata T., et al. Protection against influenza B virus infection by immunization with DNA vaccines. Vaccine 19 (2001) 1446-1455
44. Tamura T., and Sakata T. Application of in vivo electroporation to cancer gene therapy. Curr Gene Ther 3 (2003) 59-64
45. Dupuis M., Denis-Mize K., Woo C., Goldbeck C., Selby M.J., Chen M., et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 165 (2000) 2850-2858
46. Glasspool-Malone J., Somiari S., Drabick J.J., and Malone R.W. Efficient nonviral cutaneous transfection. Mol Ther 2 (2000) 140-146
47. Nicol F., Wong M., MacLaughlin F.C., Perrard J., Wilson E., Nordstrom J.L., et al. Poly-l-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electroporation. Gene Ther 9 (2002) 1351-1358
48. Hartikka J., Sukhu L., Buchner C., Hazard D., Bozoukova V., Margalith M., et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 4 (2001) 407-415
49. Pashine A., Valiante N.M., and Ulmer J.B. Targeting the innate immune response with improved vaccine adjuvants. Nat Med 11 (2005) S63-S68
50. Rabussay D., Dev N.B., Fewell J., Smith L.C., Widera G., and Zhang L. Enhancement of therapeutic drug and DNA delivery into cells by electroporation. J Phys D: Appl Phys 36 (2003) 348-363
51. Tjelle T.E., Salte R., Mathiesen I., and Kjeken R. A novel electroporation device for gene delivery in large animals and humans. Vaccine 24 (2006) 4667-4670
52. Singh B.N., and Dwivedi C. Antitumor drug delivery by tissue electroporation. Anticancer Drugs 10 (1999) 139-146
53. Hui S.W. The application of electroporation to transfect hematopoietic cells and to deliver drugs and vaccines transcutaneously for cancer treatment. Technol Cancer Res Treat 1 (2002) 373-384
54. Schaft N., Dorrie J., Muller I., Beck V., Baumann S., Schunder T., et al. A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes. Cancer Immunol Immunother 55 (2006) 1132-1141 [epub 2005 Dec 13]
55. Kishida T., Asada H., Satoh E., Tanaka S., Shinya M., Hirai H., et al. In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther 8 (2001) 1234-1240
56. Tamura T., Nishi T., Goto T., Takeshima H., Dev S.B., Ushio Y., et al. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Hum Gene Ther 12 (2001) 1265-1276
57. Wells J.M., Li L.H., Sen A., Jahreis G.P., and Hui S.W. Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 7 (2000) 541-547
58. Watanabe K., Nakazawa M., Fuse K., Hanawa H., Kodama M., Aizawa Y., et al. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 104 (2001) 1098-1100
59. Vilquin J.T., Kennel P.F., Paturneau-Jouas M., Chapdelaine P., Boissel N., Delaere P., et al. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies. Gene Ther 8 (2001) 1097-1107
60. Del Giudice G., Grillot D., Renia L., Muller I., Corradin G., Louis J.A., et al. Peptide-primed CD4+ cells and malaria sporozoites. Immunol Lett 25 (1990) 59-63
61. Franke E.D., Sette A., Sacci Jr. J., Southwood S., Corradin G., and Hoffman S.L. A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture. Infect Immunol 68 (2000) 3403-3411
62. Renia L., Marussig M.S., Grillot D., Pied S., Corradin G., Miltgen F., et al. In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc Natl Acad Sci USA 88 (1991) 7963-7967
63. Weiss W.R., Mellouk S., Houghten R.A., Sedegah M., Kumar S., Good M.F., et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 171 (1990) 763-773
64. Charoenvit Y., Majam Fallarme V., Corradin G., Sacci Jr. J.B., Wang R., Doolan D.L., et al. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immunol 67 (1999) 5604-5614
65. Tjelle T, Rabussay D, Ottensmeier C, Mathiesen I, Kjeken R. Taking electroporation-based delivery of DNA vaccination into humans; A generic clinical protocol. In: Li S, editor. Methods in Molecular Biology, vol. 10. Electroporation Protocols: Experimental and Clinical Medicine, Totowa, NJ: Humana Press, Inc.; in press.
66. Rabussay D. Applicator and electrode design for in vivo DNA delivery by electroporation. In: S.Li, editor. Methods in Molecular Biology, vol. 10. Electroporation Protocols: Experimental and Clinical Medicine, Totowa, NJ: Humana Press, Inc.; in press.